These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans. Vaccarella G, Pelella R. Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239 [Abstract] [Full Text] [Related]
6. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Levi M, Toh CH, Thachil J, Watson HG. Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477 [Abstract] [Full Text] [Related]
7. Protein C replacement in severe meningococcemia: rationale and clinical experience. Alberio L, Lämmle B, Esmon CT. Clin Infect Dis; 2001 May 01; 32(9):1338-46. PubMed ID: 11303270 [Abstract] [Full Text] [Related]
13. [Meningococcal purpura fulminans: treatment with recombinant protein C activator in 3 cases]. Salinas U, Unzueta J, Vidarte MA, Rodrigo MP, Gómez JJ, Aguilera L. Rev Esp Anestesiol Reanim; 2007 Oct 01; 54(8):503-6. PubMed ID: 17993100 [Abstract] [Full Text] [Related]
14. Management of neonatal purpura fulminans with severe protein C deficiency. Sen K, Roy A. Indian Pediatr; 2006 Jun 01; 43(6):542-5. PubMed ID: 16820665 [Abstract] [Full Text] [Related]
17. Use of protein C concentrate in neonatal period. De Carolis MP. Minerva Pediatr; 2010 Jun 01; 62(3 Suppl 1):29-30. PubMed ID: 21089715 [Abstract] [Full Text] [Related]
20. Human protein C concentrates for replacement therapy in congenital and acquired protein C deficiency. Knoebl PN. Drugs Today (Barc); 2008 Jun 01; 44(6):429-41. PubMed ID: 18596997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]